- Home
- EFSI vs RCEL Comparison
EFSI vs RCEL Comparison
Compare EFSI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSI
- RCEL
- Stock Information
- Founded
- EFSI 1881
- RCEL N/A
- Country
- EFSI United States
- RCEL United States
- Employees
- EFSI N/A
- RCEL N/A
- Industry
- EFSI Major Banks
- RCEL Medical/Dental Instruments
- Sector
- EFSI Finance
- RCEL Health Care
- Exchange
- EFSI Nasdaq
- RCEL Nasdaq
- Market Cap
- EFSI 161.4M
- RCEL 161.5M
- IPO Year
- EFSI N/A
- RCEL N/A
- Fundamental
- Price
- EFSI $30.78
- RCEL $5.35
- Analyst Decision
- EFSI Strong Buy
- RCEL Strong Buy
- Analyst Count
- EFSI 2
- RCEL 4
- Target Price
- EFSI $40.00
- RCEL $16.50
- AVG Volume (30 Days)
- EFSI 55.2K
- RCEL 326.4K
- Earning Date
- EFSI 08-25-2025
- RCEL 08-07-2025
- Dividend Yield
- EFSI 4.03%
- RCEL N/A
- EPS Growth
- EFSI N/A
- RCEL N/A
- EPS
- EFSI 1.52
- RCEL N/A
- Revenue
- EFSI $58,067,000.00
- RCEL $71,661,000.00
- Revenue This Year
- EFSI $3.16
- RCEL $57.16
- Revenue Next Year
- EFSI $22.35
- RCEL $36.69
- P/E Ratio
- EFSI $20.20
- RCEL N/A
- Revenue Growth
- EFSI N/A
- RCEL 41.35
- 52 Week Low
- EFSI $28.70
- RCEL $4.71
- 52 Week High
- EFSI $36.93
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- EFSI N/A
- RCEL 34.33
- Support Level
- EFSI N/A
- RCEL $4.71
- Resistance Level
- EFSI N/A
- RCEL $5.45
- Average True Range (ATR)
- EFSI 0.00
- RCEL 0.33
- MACD
- EFSI 0.00
- RCEL 0.01
- Stochastic Oscillator
- EFSI 0.00
- RCEL 25.31
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.